Author: GlobeNewswire

VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company committed…

Upcoming Change Reflects the Company’s Focus on Oral Delivery of BiotherapeuticsSAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) — Progenity, Inc.…

LAS VEGAS, April 12, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based…

VANCOUVER, Washington, April 12, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company…

NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer…

Halo’s Ground-Breaking Brand of Super Premium, Natural Pet Food will be Available at 600+ Pet Supplies Plus Locations Beginning in…

The potential of spermine analogue SBP-101 (diethyl dihydroxyhomospermine) as a polyamine metabolism modulator in ovarian cancerMINNEAPOLIS, April 12, 2022 (GLOBE…

SOUTH SAN FRANCISCO, Calif., April 12, 2022 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering…

LAWRENCEVILLE, N.J., April 12, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines,…

PASADENA, CA, April 12, 2022 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage pharmaceutical company focused on…